Novartis India Share Price

Q: What is Novartis India share price today?

Novartis India share price is ₹1,469.40 as on 03 Jul, 2026, 15:46 IST.

Q: How has the Novartis India share price performed in the past?

In the last 1 year, Novartis India delivered a return of 47.61%. The Novartis India share price hit a high of ₹1,589.20 and low of ₹950.00.

Q: How much is the Mutual Fund shareholding in Novartis India shares?

The Mutual Fund Shareholding in Novartis India was 0.00% at the end of Mar 2026.

Q: What is the the 52-week high and low of Novartis India shares ?

The 52-week high and low of Novartis India share is ₹1,589.20 and ₹950.00 as of 03 Jul, 2026.

Q: What is the market cap of Novartis India?

The market capitalisation of Novartis India is ₹3,586.83 Crores as on 03 Jul, 2026.

Q: What are the stock symbols of Novartis India?

The stock symbol of Novartis India is NOVARTIND on the NSE, 500672 on the BSE, and the ISIN is INE234A01025.

Q: What was yesterday's closing price of Novartis India shares ?

Novartis India shares closed yesterday at ₹1,453.60 on NSE & ₹1,452.70 on BSE

Q: How to buy Novartis India shares?

To buy Novartis India shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.

Q: Can I buy Novartis India shares on Holidays?

No, shares of Novartis India or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Novartis India shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

Q: What is the PE and PB ratio of Novartis India?

The PE and PB ratio of Novartis India is 38.49 and 4.39 respectively, as on 03 Jul, 2026, 15:46 IST.

NSE: NOVARTIND

Trading

₹ 1,469.40

+₹15.80 (1.09%)

Last updated 03 Jul, 2026, 15:46 IST

Novartis India Share Price Today

As of 5 Jul 2026, Novartis India share price is ₹1,469.40. The stock opened at ₹1,457.00, compared to its previous close of ₹1,453.60. During today's trading session, Novartis India share price moved in the range of ₹1,455.00 to ₹1,489.10, with an average price of ₹1,472.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹950.00 and a high of ₹1,589.20. On the performance front, Novartis India share price has increased by 47.61% over the last six months and is up 47.61% on a year-on-year basis.

₹1,455.00

1.09% up today

₹1,489.10

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 7.36 % in last 1 month

Shareholding Pattern

DIIDII decreased stake by 16.01%

Shareholding Pattern

FIIFII decreased stake by 6.42%

Novartis India Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹7,63,721+₹2,63,721 (+52.74%)

3 Year

₹7,12,955+₹2,12,955 (+42.59%)

5 Year

₹7,12,955+₹2,12,955 (+42.59%)

Open

₹1,457.00

High

₹1,489.10

Low

₹1,455.00

Prev. close

₹1,453.60

₹1,175.60₹1,763.20

Circuit Low

Circuit High

₹950.00₹1,589.20

52-Week Low

52-Week High

Circuit

₹1,175.60

₹1,763.20

52-week

₹950.00

₹1,589.20

Novartis India Shareholder Returns

Novartis India Share Price History

Mkt Cap Cr

3,586.83

P/E

38.49

P/B

4.39

ROE

11.39%

D/E

0.00

ROCE

15.94%

Div. Yield

0.00%

EPS(TTM)

37.74

Turnover

0.43

EV/EBITDA

21.84

Net Margin

0.00%

Op. Margin

0.00%

ROA

9.52%

Quick Ratio

0.00

Curr. Ratio

5.36

Mkt Cap Cr

3,586.83

P/E

38.49

P/B

4.39

ROE

11.39%

D/E

0.00

ROCE

15.94%

Div. Yield

0.00%

EPS(TTM)

37.74

Turnover

0.43

EV/EBITDA

21.84

Net Margin

0.00%

Op. Margin

0.00%

ROA

9.52%

Quick Ratio

0.00

Curr. Ratio

5.36

Based on fundamentals, this stock's

Performance

Excellent

Novartis India outperforming all market indices

Valuation

Overvalued

Novartis India appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,49,048.00	39.02	5.37	13.74%	0.61	17.33%	93.24	0.85%	0.56	10.90
Divis Laboratories	1,77,179.00	69.00	10.57	15.32%	0.00	19.56%	629.49	0.45%	0.58	98.19
Torrent Pharmaceuticals	1,57,804.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,17,642.00	25.47	2.87	11.79%	0.00	15.66%	2.89	1.06%	0.49	43.52
Dr. Reddy's Laboratories	1,12,368.00	27.03	2.97	11.07%	0.18	12.54%	375.78	0.59%	0.63	38.68
Zydus Lifesciences	1,10,651.00	21.60	4.08	18.59%	0.31	17.35%	235.25	0.09%	0.39	35.38
Lupin	1,09,676.00	20.48	4.89	23.76%	0.04	24.88%	659.05	0.75%	0.61	129.18
Mankind Pharma	1,02,729.00	53.00	6.30	11.74%	0.34	13.13%	397.02	0.04%	0.54	49.37
Aurobindo Pharma	90,608.00	25.87	2.39	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	82,398.90	60.26	10.10	18.21%	0.45	16.70%	10.19	0.20%	0.97	13.72

Novartis India Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹356.27	₹335.07	₹378.74	₹399.87
Other Income	₹41.96	₹61.68	₹58.11	₹33.19
Total Revenue	₹398.23	₹396.75	₹436.85	₹433.06
Total Expenses	₹267.81	₹273.91	₹321.47	₹387.24
Profit Before Tax	₹130.42	₹122.84	₹115.38	-₹3.82
Tax	₹29.52	₹37.65	₹12.02	-₹0.10
Profit After Tax	₹100.90	₹85.19	₹103.36	-₹3.72
EPS - Basic	₹40.87	₹34.50	₹41.86	-₹1.51
EPS - Diluted	₹40.87	₹34.50	₹41.86	-₹1.51

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Profit before tax	₹122.84	₹115.38	-₹3.82	₹40.04
Income before WC changes	₹66.09	₹66.46	-₹9.46	₹35.06
Change in Assets	₹21.49	₹23.43	₹40.65	₹1.94
Change in Liabilities	-₹12.45	-₹47.43	₹26.07	-₹71.02
Change in WC	₹9.04	-₹24.00	₹66.72	-₹69.08
Cash flow from Operations	₹113.40	₹44.80	₹38.67	-₹69.21
Cash flow from Investing	₹33.13	-₹153.25	₹87.04	₹95.16
Cash flow from Financing	-₹120.99	-₹30.48	-₹35.63	-₹36.80
Total Cash Flow	₹25.54	-₹138.93	₹90.08	-₹10.85
Cash (Start of the year)	₹19.42	₹158.35	₹68.27	₹79.12
Cash (End of the year)	₹44.96	₹19.42	₹158.35	₹68.27

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹201.99	₹225.67	₹305.61	₹248.84
Current Assets	₹745.82	₹699.26	₹677.33	₹708.73
Total Assets	₹947.81	₹924.93	₹982.94	₹957.57
Current Liabilities	₹142.05	₹157.20	₹159.49	₹216.42
Net Current Asset	₹603.77	₹542.06	₹517.84	₹492.31
Non-Current Liabilities	₹20.80	₹22.91	₹47.79	₹49.45
Equity Capital	₹784.96	₹744.82	₹775.66	₹691.70
Total Equity & Liabilities	₹947.81	₹924.93	₹982.94	₹957.57

* All values are in INR Crore

Qty

Bid

Ask

Qty

Bid Total: 0

Ask Total: 0

Buy orders: 0%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Neutral

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

67.81

Neutral

ATR (14)

67.14

Neutral

STOCH(9,6)

48.76

Neutral

STOCH RSI (14)

54.69

Neutral

ADX(9)

36.18

Bearish

UO(9)

34.43

Neutral

ROC(12)

11.02

Bullish

WillR(14)

-30.99

Neutral

Period

Simple value

Exponential vaue

1448.36

1452.92

10D

1450.44

1437.89

20D

1393.92

1410.56

50D

1283.76

1454.22

100D

1272.55

About Novartis India

ISIN

INE234A01025

Sector Market Cap

₹ 3,586.83 Cr

Novartis India Limited is an India-based company. The Company is primarily engaged in the business of trading of Pharmaceuticals. It operates in the Pharmaceutical business segment. The Company’s brands hold key positions in therapeutic areas, such as, Voveran, which is the brand for bone and pain; Simulect, Certican, Sandimmun, Neoral, and Myfortic, which is the brand for transplantation immunology; and Tegrital and Exelon, which is the brand for neurosciences.

Know more

Promoters

70.68%

FII

0.17%

Other DII

0.53%

Retail and other

28.61%

Mutual funds

0.00%

Foreign institutions - FII